By limiting joint damage, disability is reduced. The primary treatment for rheumatoid arthritis is medication to reduce immune system activity and inflammation. Five categories of drugs commonly used ...
RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM ...
In RA, the immune system attacks the lining of the joint (called the synovium) and causes inflammation, which leads to joint damage. Without treatment, this disease can lead to serious disability.
There is a bidirectional association between rheumatoid arthritis ... immune process and prevent long-term damage. In recent times, the newer group of biologics has increased treatment options.